Shares of weapons and body-camera maker Axon rose by almost 30% mid-week after an earnings announcement that beat analysts’ expectations. According to The Motley Fool, while Axon's weapons sales rose by 10% during Q4 2017, the company’s software and sensors segment, which includes its body cameras manufacturing, saw its revenue increase 27% during the period. In a note sent out late last week, analyst Brian Wieser said he believes “many investors are underestimating how much money is being made in this space.”
Shares of weapons and body-camera maker Axon rose by almost 30% mid-week after an earnings announcement that beat analysts’ expectations. According to The Motley Fool, while Axon's weapons sales rose by 10% during Q4 2017, the company’s software and sensors segment, which includes its body cameras manufacturing, saw its revenue increase 27% during the period. The firm has plans for more body-camera product launches during 2018.